v3.26.1
Restatement of Previously Issued Financial Statements (Tables)
 3 Months Ended
Mar. 31, 2026
Restatement of Previously Issued Financial Statements [Abstract]  
Financial Statements - Restatement Reconciliation Tables
The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the periods indicated. The amounts in the "As Restated" columns are the updated amounts including the impacts from the restatement. Financial statement line items and subtotals that were not impacted by the restatement adjustments have been omitted for enhanced clarity.
 
Balance Sheet – as of December 31, 2025:
 
             
    As Previously Reported     Adjustment     As Restated  
                
Deferred tax assets, net  $ —    $58,709   $58,709 
Total assets   26,237,315    58,709    26,296,024 
                
Accrued expenses   2,160,366    1,907,251    4,067,617 
Total current liabilities   13,293,479    1,907,251    15,200,730 
Deferred tax liabilities, net   355,646    (355,646)     -  
Total liabilities   13,883,222    1,551,605    15,434,827 
                
Accumulated deficit   (18,054,278)    (1,492,896)    (19,547,174) 
Total stockholders’ equity  $12,354,093   $(1,492,896)   $10,861,197 
 
Balance Sheet – as of March 31, 2026:
 
             
    As Previously Reported       Adjustment       As Restated  
                
Deferred tax assets, net
 $—    $58,709   $58,709 
Total assets
  25,149,169    58,709    25,207,878 
                
Accrued expenses
  1,171,783    2,017,886    3,189,669 
Total current liabilities
  12,108,237    2,017,886    14,126,123 
Deferred tax liabilities, net
  355,646    (355,646)     -  
Total liabilities
  12,711,098    1,662,240    14,373,338 
                
Accumulated deficit
  (17,995,966)    (1,603,531)    (19,599,497) 
Total stockholders’ equity
 $12,438,071   $(1,603,531)   $10,834,540 
 
Statement of Operations – Three Months Ended March 31, 2026:
 
             
    As Previously Reported     Adjustment     As Restated  
                
Selling, general, and administrative expenses
 $2,505,880   $121,757   $2,627,637 
Total operating expenses
  5,080,605    121,757    5,202,362 
Loss from operations
  (93,727)    (121,757)    (215,484) 
Other income, net
  169,803    (29,129)    140,674 
Income (loss) before income taxes
  76,076    (150,886)    (74,810) 
Benefit (provision) for income taxes
  (17,764)    40,251    22,487 
Net income (loss)
  58,312    (110,635)    (52,323) 
                
Net income (loss) per share – Basic and diluted
 $0.01   $(0.01)   $-  
Statement of Operations – Three Months Ended March 31, 2025:
 
             
    As Previously Reported     Adjustment     As Restated  
                
Selling, general, and administrative expenses
 $2,476,951   $136,595   $2,613,546 
Total operating expenses
  4,846,045    136,595    4,982,640 
Income from operations
  25,367    (136,595)    (111,228) 
Other income, net
  180,833    (22,966)    157,867 
Income before income taxes
  206,200    (159,561)    46,639 
Provision for income taxes
  (47,138)    (7,310)    (54,448) 
Net income (loss)
  159,062    (166,871)    (7,809) 
                
Net income (loss) per share – Basic and diluted
 $0.01   $(0.01)   $-  
 
Statements of Stockholders' Equity – Three Months Ended March 31, 2026:
 
             
    As Previously Reported     Adjustment     As Restated  
                
Balance as of January 1, 2026
              
Accumulated deficit
 $(18,054,278)   $(1,492,896)   $(19,547,174) 
Total stockholders’ equity
  12,354,093    (1,492,896)    10,861,197 
                
Balance as of March 31, 2026
              
Accumulated deficit
 $(17,995,966)   $(1,603,531)   $(19,599,497) 
Total stockholders’ equity
  12,438,071    (1,603,531)    10,834,540 
Statements of Stockholders' Equity – Three Months Ended March 31, 2025:
 
             
    As Previously Reported     Adjustment     As Restated  
                
Balance as of January 1, 2025
              
Accumulated deficit
 $(19,072,209)   $(986,126)   $(20,058,335) 
Total stockholders’ equity
  11,141,746    (986,126)    10,155,620 
                
Balance as of March 31, 2025
              
Accumulated deficit
 $(18,913,147)   $(1,152,997)   $(20,066,144) 
Total stockholders’ equity
  11,328,093    (1,152,997)    10,175,096 
Statements of Cash Flows – Three Months Ended March 31, 2026:
 
             
    As Previously Reported     Adjustment     As Restated  
                
Cash flows from operating activities:               
   Net income (loss)  $58,312   $(110,635)   $(52,323) 
                
Changes in operating assets and liabilities:               
Accrued expenses   (988,583)    110,635    (877,948) 
Statements of Cash Flows – Three Months Ended March 31, 2025:
 
             
    As Previously Reported         Adjustment         As Restated  
                
Cash flows from operating activities:               
   Net income (loss)  $159,062   $(166,871)   $(7,809) 
                
Changes in operating assets and liabilities:               
     Accrued expenses   (769,283)    166,871    (602,412)